Rabah Redjoul

Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

Rabah Redjoul, Anne Le Bouter, Vincent Parinet et al. · The Lancet Haematology · 2021 · 77 citations · Full text

Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program

Christine Robin, Anne Thiébaut, Sophie Alain et al. · Biology of Blood and Marrow Transplantation · 2020 · 73 citations · Full text

Vaccination, Cytomegalovirus Infection, Transplantation +15

Economic burden of preemptive treatment of CMV infection after allogeneic stem cell transplantation: a retrospective study of 208 consecutive patients

Christine Robin, F. Hémery, Christel Dindorf et al. · BMC Infectious Diseases · 2017 · 48 citations · Full text

Allogeneic hematopoietic stem cell transplantation for <scp>T</scp>‐prolymphocytic leukemia: a report from the <scp>F</scp>rench society for stem cell transplantation (<scp>SFGM</scp>‐<scp>TC</scp>)

Thierry Guillaume, Yves Béguin, Reza Tabrizi et al. · European Journal Of Haematology · 2014 · 39 citations · Full text

Hematological Malignancy, Cell Therapy, Conventional Chemotherapy +14

Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease

Florent Delbos, Walid Barhoumi, Ludovic Cabanne et al. · Biology of Blood and Marrow Transplantation · 2015 · 29 citations · Full text

Histocompatibility, Hla, Immunology +21